IP Library Granted Patent US 7,598,035
Granted Patent B2
US 7,598,035 · App. 10/962,337 · Granted Oct 6, 2009

Method and compositions for ordering restriction fragments

Assignee: Solexa, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,598,035
App. No.
10/962,337
Granted
Oct 6, 2009
Kind
B2
Abstract

The invention provides a method for constructing a high resolution physical map of a polynucleotide. In accordance with the invention, nucleotide sequences are determined at the ends of restriction fragments produced by a plurality of digestions with a plurality of combinations of restriction endonucleases so that a pair of nucleotide sequences is obtained for each restriction fragment. A physical map of the polynucleotide is constructed by ordering the pairs of sequences by matching the identical sequences among the pairs.

Claims (9)

1. A method of forming a linked pair of segments from each fragment of a population of polynucleotide fragments, wherein each said fragment is in a vector, said vector comprises two type IIs restriction endonuclease recognition sites, one of said type IIs restriction endonuclease recognition sites is adjacent to one end of the fragment and another of said type IIs restriction endonuclease recognition sites is adjacent to another end of the fragment, and one or more type IIs restriction endonucleases recognizing said type IIs restriction endonuclease recognition sites have two cleavage sites within the interior of the fragment, the method comprising:

treating each said vector and fragment with said one or more type IIs restriction endonucleases recognizing said type IIs restriction recognition sites, such that each fragment is cleaved at said cleavage sites, thereby removing the region of the fragment between said cleavage sites, whereby a pair of segments from said fragment remain connected to each other via said vector after said removing and each of said segments has a cleaved end; and

ligating together the cleaved ends produced by said removing thereby forming a linked pair of segments from each said fragment.

2. The method of claim 1 wherein the two type IIs recognition sites are recognized by the same type IIs restriction endonuclease.

3. A method of forming linearized vectors having pairs of segments from a population of polynucleotide fragments, the method comprising the steps of:

i) inserting each of said polynucleotide fragments from said population into a vector having two type IIs restriction endonuclease recognition sites and forming vectors containing said polynucleotide fragments such that each of the vectors containing said polynucleotide fragments comprises a fragment from said population of polynucleotide fragments, one of said type IIs restriction endonuclease recognition sites in each of the vectors containing said polynucleotide fragments is adjacent to one end of the fragment and another of said type IIs endonuclease recognition sites in each of the vectors containing said polynucleotide fragments is adjacent to another end of the fragment, and one or more type IIs restriction endonucleases recognizing said type IIs restriction endonuclease recognition sites have two cleavage sites within the interior of the fragment; and

ii) treating each of the vectors containing said polynucleotide fragments with said one or more type IIs restriction endonucleases recognizing the type IIs restriction endonuclease recognition sites and producing linearized vectors having pairs of segments wherein each of said linearized vectors having pairs of segments has a pair of segments of the fragment, one of said pair of segments is located at one end of each of the linearized vectors, and another of said pair of segments is located at another end of each of the linearized vectors.

4. The method of claim 3 , wherein said type IIs recognition sites are recognized by the same type IIs restriction endonuclease.

5. The method of claim 3 , further comprising the step of re-circularizing each of the linearized vectors, by ligating the pair of segments together.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2010
From: MACEVICZ, STEPHEN C.
To: LYNX THERAPEUTICS, INC.
Reel/Frame 024812/0910 →
MERGER Recorded Aug 11, 2010
From: SOLEXA, INC.
To: ILLUMINA, INC.
Reel/Frame 024812/0913 →
MERGER Recorded Oct 29, 2007
From: LYNX THERAPEUTICS, INC.
To: SOLEXA, INC.
Reel/Frame 020031/0061 →
Continuity (4)
Division 1070611800 · Nov 12, 2003
Division 0954974800 · Apr 14, 2000
Division 0902812800 · Feb 23, 1998
Related Publication 20050042673A1 · Feb 24, 2005